National Aspergillosis Centre (NAC) at Wythenshawe Hospital, Manchester, providing specialist NHS care, research and support for people with aspergillosis.

About the National Aspergillosis Centre (NAC)

National Aspergillosis Centre (NAC) at Wythenshawe Hospital, Manchester, providing specialist NHS care, research and support for people with aspergillosis.
The National Aspergillosis Centre (NAC), based at Wythenshawe Hospital in Manchester, is the UK's specialist NHS service for chronic pulmonary aspergillosis and other complex Aspergillus-related diseases.

The UK's specialist centre for aspergillosis

The National Aspergillosis Centre (NAC) is a specialist NHS service based at Wythenshawe Hospital in Manchester, part of Manchester University NHS Foundation Trust.

NAC provides expert assessment, diagnosis, treatment and long-term management for people with complex forms of aspergillosis, particularly Chronic Pulmonary Aspergillosis (CPA). The centre also supports healthcare professionals across the United Kingdom with specialist advice, guidance and multidisciplinary case discussion.

Alongside its clinical work, NAC supports research, education and patient engagement, helping improve understanding and care of aspergillosis nationally and internationally.

National Aspergillosis Centre at a glance

Service National Aspergillosis Centre (NAC)
Location Wythenshawe Hospital, Manchester
Organisation Manchester University NHS Foundation Trust
Specialty Complex aspergillosis care
National role NHS specialist referral service
Supports Patients and healthcare professionals across the UK

What is aspergillosis?

Aspergillosis is a group of conditions caused by fungi from the Aspergillus family. These fungi are commonly found in the environment, and most people breathe in Aspergillus spores every day without becoming ill.

In some circumstances, however, Aspergillus can cause disease. This may occur because of underlying lung disease, asthma or allergic conditions, a weakened immune system, structural lung damage or previous lung infections.

Which conditions does NAC help manage?

Chronic Pulmonary Aspergillosis (CPA)

CPA is a long-term fungal infection of the lungs that can develop in people who already have lung damage or cavities caused by previous illness.

Allergic Bronchopulmonary Aspergillosis (ABPA)

ABPA is an allergic reaction to Aspergillus that most commonly affects people with asthma or cystic fibrosis.

Aspergillus bronchitis

Aspergillus bronchitis is a chronic airway infection in which Aspergillus is repeatedly identified in the airways and contributes to ongoing respiratory symptoms.

Other complex Aspergillus-related conditions

  • Aspergillus nodules
  • Severe Asthma with Fungal Sensitisation (SAFS)
  • complex diagnostic cases
  • difficult-to-treat aspergillosis
  • antifungal treatment complications
  • therapeutic drug monitoring

Not all patients with aspergillosis need referral to NAC. Many people receive excellent care through local respiratory, infectious diseases, allergy or severe asthma services.

How do referrals work?

Patients are normally referred by a healthcare professional. Referrals may come from respiratory physicians, infectious diseases specialists, immunologists, severe asthma services or general practitioners working with specialist teams.

NAC also supports clinicians through remote advice services and multidisciplinary discussions, helping many patients receive specialist input without needing regular travel to Manchester.

What happens at a NAC appointment?

Every patient is different, but assessment may include:

  • review of symptoms and medical history
  • review of computed tomography (CT) scans and other imaging
  • blood test review
  • review of microbiology and fungal test results
  • assessment of antifungal treatment
  • therapeutic drug monitoring
  • discussion of future treatment options

Patients often continue to receive much of their care locally, with specialist recommendations provided by NAC.

Specialist aspergillosis care across the UK

Although NAC is the UK's national specialist centre for chronic aspergillosis, specialist care is also provided through many hospitals and specialist services across the country.

Depending on the condition involved, patients may receive care from respiratory medicine services, bronchiectasis clinics, severe asthma centres, infectious diseases departments, allergy services or immunology services.

The most appropriate service depends on the type of aspergillosis and the patient's individual circumstances.

Research and innovation

Research is a central part of the work carried out by NAC and its partners. Areas of ongoing research include improved diagnostics, new antifungal medications, biologic therapies, therapeutic drug monitoring, imaging, disease monitoring, patient experience and clinical trials.

Education and patient support

The National Aspergillosis Centre is committed to helping patients and carers understand their condition and access reliable information.

Resources available through aspergillosis.org include:

  • over 1,000 patient information articles
  • condition-specific Knowledge Hubs
  • support meetings
  • recorded educational talks
  • patient stories
  • research updates
  • guidance for carers and families

Working together

Effective aspergillosis care relies on collaboration between patients, carers, local healthcare teams and specialist services.

NAC works closely with healthcare professionals, researchers, patient organisations and charities to improve awareness, diagnosis, treatment and support for people living with aspergillosis.

Frequently asked questions

What is the National Aspergillosis Centre?

The National Aspergillosis Centre is a specialist NHS service based at Wythenshawe Hospital in Manchester. It provides expert care and advice for complex forms of aspergillosis, especially Chronic Pulmonary Aspergillosis.

Where is NAC located?

NAC is based at Wythenshawe Hospital in Manchester, part of Manchester University NHS Foundation Trust.

Who can be referred to NAC?

Patients with complex or difficult-to-manage aspergillosis may be referred by a healthcare professional. Many referrals involve Chronic Pulmonary Aspergillosis, but NAC also provides advice for other Aspergillus-related conditions.

Can I refer myself to NAC?

Patients are normally referred by a healthcare professional. If you believe specialist input may be helpful, discuss this with your clinical team.

Do I have to live near Manchester?

No. Patients are referred from throughout the United Kingdom, and NAC also supports clinicians remotely.

Does everyone with aspergillosis need NAC?

No. Many patients are managed successfully by local specialist teams. NAC is primarily involved in complex cases and specialist advice.

Does NAC only treat CPA?

No. Although NAC is especially known for Chronic Pulmonary Aspergillosis, it also provides advice and support for a range of complex Aspergillus-related conditions.

What happens during a NAC appointment?

A NAC appointment may include review of symptoms, scans, blood tests, microbiology results, antifungal treatment, drug levels and future treatment options.

Does NAC provide patient support?

Yes. Through aspergillosis.org and the NAC CARES programme, patients and carers can access educational resources, support meetings and community activities.

Suggested links

About this page

This page was prepared by the National Aspergillosis Centre CARES team to explain the role of the National Aspergillosis Centre and how specialist aspergillosis care is provided within the UK healthcare system.

Last reviewed: June 2026

by GAtherton

Patient journey from delayed diagnosis to specialist aspergillosis care supported by respiratory medicine, medical mycology, microbiology and multidisciplinary healthcare teams.

Why the UK’s Infection Specialist Workforce Matters to People Living with Aspergillosis

Patient journey from delayed diagnosis to specialist aspergillosis care supported by respiratory medicine, medical mycology, microbiology and multidisciplinary healthcare teams.
Specialist healthcare professionals including respiratory clinicians, microbiologists, medical mycologists, nurses and pharmacists play a vital role in diagnosing and managing aspergillosis.

A new national report has called for urgent action to strengthen and modernise the UK’s infection-specialist workforce. The report, Infection Prevention and Management in the UK: The Infection-Specialist Workforce, was published by the Healthcare Infection Society and partner organisations across the infection community.

At first glance, workforce planning may sound like an issue mainly for hospitals, universities, laboratories and policymakers. However, for people living with aspergillosis and other complex fungal diseases, the availability of specialist expertise can directly affect diagnosis, treatment, access to advice and long-term outcomes.

Why this matters to patients

Aspergillosis is not a single disease. It includes conditions such as Allergic Bronchopulmonary Aspergillosis (ABPA), Chronic Pulmonary Aspergillosis (CPA), Aspergillus bronchitis and invasive aspergillosis.

These conditions are often complex, uncommon and difficult to recognise. Many patients describe long journeys to diagnosis, sometimes involving repeated chest infections, worsening asthma, unexplained fatigue, weight loss, breathlessness, abnormal scans or uncertainty about the meaning of test results.

When specialist infection, respiratory, laboratory and mycology expertise is difficult to access, patients may face longer waits for diagnosis, referral and treatment decisions.

Why this matters to professionals

The report highlights the central role of the infection-specialist workforce in clinical care, diagnostics, infection prevention and control, antimicrobial stewardship, public health and system preparedness.

This workforce includes infectious diseases physicians, clinical microbiologists, virologists, medical mycologists, infection prevention specialists, specialist nurses, antimicrobial pharmacists, biomedical scientists and clinical scientists.

For fungal disease, this multidisciplinary expertise is essential. Diagnosing and managing aspergillosis often requires careful interpretation of clinical history, imaging, fungal culture, Aspergillus antibody testing, galactomannan, molecular diagnostics, antifungal drug levels, susceptibility results and treatment toxicity monitoring.

What workforce shortages can mean in practice

For patients with aspergillosis, workforce pressures may contribute to:

  • Delays in recognising possible fungal disease.
  • Delays in referral to specialist services.
  • Variation in access to expertise between regions.
  • Longer waits for interpretation of specialist tests.
  • Reduced capacity for multidisciplinary team discussion.
  • Greater pressure on specialist centres and laboratories.
  • Delays in accessing newer diagnostics, antifungal treatments or clinical trials.

For professionals, these pressures can make already complex work more difficult. Clinicians may be managing patients with rare fungal disease alongside heavy general respiratory, microbiology, infectious diseases or laboratory workloads. Specialist advice networks and reference services therefore become increasingly important.

The importance of medical mycology

Fungal diseases remain under-recognised compared with many bacterial and viral infections, despite causing serious illness in people with chronic lung disease, immune suppression, transplantation, cancer treatment or prolonged critical illness.

Medical mycology is a highly specialised area. It supports accurate diagnosis, antifungal treatment selection, interpretation of complex tests and recognition of emerging resistance. Without sufficient mycology expertise, advances in fungal diagnostics and treatment may not reach patients quickly or consistently.

The role of specialist centres

The UK benefits from specialist services such as the National Aspergillosis Centre, which provides expert assessment, multidisciplinary review and advice for patients with complex forms of aspergillosis.

However, specialist centres cannot work in isolation. Earlier recognition by GPs, respiratory teams, radiologists, microbiologists, infectious diseases teams and local laboratories is vital. Strong referral pathways help patients reach the right expertise at the right time.

For rare fungal diseases, national specialist centres and local services need to function as part of a connected system rather than as separate parts of care.

A patient safety and equity issue

Access to infection expertise is also an equity issue. Patients should not face very different chances of diagnosis or specialist input depending on where they live.

Strengthening the infection-specialist workforce could help reduce variation in care, support earlier diagnosis and improve access to expert advice across the UK.

Looking ahead

New antifungal drugs, improved diagnostics, molecular testing, genomics and clinical trials are creating new opportunities to improve aspergillosis care.

But innovation only helps patients if there are trained professionals available to recognise fungal disease, request appropriate tests, interpret results, prescribe and monitor treatment, and work across multidisciplinary teams.

For patients and professionals alike, the message is clear: strengthening the UK’s infection-specialist workforce is not simply a staffing issue. It is essential for earlier diagnosis, safer treatment, better access to expertise and more equitable care for people living with complex fungal diseases.

What does this mean for people living with aspergillosis?

  • Specialist expertise can help shorten the journey to diagnosis.
  • Better workforce capacity can improve access to advice and referral.
  • Strong laboratory services are essential for accurate fungal diagnosis.
  • Medical mycology expertise helps guide safe and effective treatment.
  • More consistent access to specialist care could reduce regional inequality.

Further reading

Frequently Asked Questions

Why are infection specialists important for aspergillosis?

Aspergillosis can be difficult to diagnose and manage. Infection specialists, respiratory clinicians, microbiologists and medical mycologists help identify fungal disease, interpret specialised tests and guide treatment decisions.

What is medical mycology?

Medical mycology is the branch of medicine and laboratory science concerned with fungal diseases affecting humans. Specialists in medical mycology help diagnose and manage infections caused by fungi such as Aspergillus.

Why can aspergillosis take a long time to diagnose?

The symptoms of aspergillosis often overlap with those of more common respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and recurrent chest infections. Specialist investigations and expert interpretation are frequently required.

How could workforce shortages affect patients?

Workforce shortages may contribute to delays in diagnosis, referral and access to specialist advice. They can also place additional pressure on laboratories, multidisciplinary teams and specialist centres.

What role do specialist laboratories play?

Specialist laboratories perform fungal cultures, Aspergillus antibody testing, antigen testing, molecular diagnostics and antifungal susceptibility testing. These investigations are often essential for accurate diagnosis and treatment planning.

What is the National Aspergillosis Centre?

The National Aspergillosis Centre (NAC) is a UK specialist service providing expert assessment, multidisciplinary review and management advice for patients with complex aspergillosis.

Will new treatments solve these problems?

New antifungal medicines and diagnostic technologies offer significant opportunities to improve care. However, trained healthcare professionals are still needed to recognise disease, request investigations, interpret results and monitor treatment safely.

How can patients help improve awareness of aspergillosis?

Patients can help by sharing reliable information, supporting awareness campaigns, participating in patient groups and, where appropriate, contributing to research and patient involvement activities.

Last reviewed: June 2026

Suggested audience: Patients, carers, respiratory clinicians, infectious diseases clinicians, microbiologists, medical mycologists, specialist nurses, pharmacists, biomedical scientists, clinical scientists, commissioners and service planners.

by GAtherton

National Aspergillosis Centre infographic showing specialist care, patient support, education, research and multidisciplinary services for Chronic Pulmonary Aspergillosis patients across the UK.

More Than a Referral Centre: How the National Aspergillosis Centre Supports Patients and Healthcare Professionals Across the UK

National Aspergillosis Centre infographic showing specialist care, patient support, education, research and multidisciplinary services for Chronic Pulmonary Aspergillosis patients across the UK.
The National Aspergillosis Centre provides specialist diagnosis, treatment, patient support, education and research for people living with Chronic Pulmonary Aspergillosis throughout the UK.

Combining specialist clinical care, diagnostics, multidisciplinary expertise, patient support, education and research to improve outcomes for people living with Chronic Pulmonary Aspergillosis.

The National Aspergillosis Centre (NAC) was established by NHS England to provide highly specialised care for people living with Chronic Pulmonary Aspergillosis (CPA), a serious fungal lung disease that can develop in patients with pre-existing respiratory conditions.

Over the last sixteen years the service has evolved into much more than a referral clinic. Today, NAC combines specialist clinical care, advanced diagnostics, multidisciplinary expertise, patient support, education and research, working alongside local healthcare teams throughout the UK.

Many clinicians are familiar with NAC as a specialist referral service. However, fewer may be aware of the breadth of support available through the centre, including specialist multidisciplinary team discussions, diagnostic expertise, physiotherapy, nursing support, pharmacy services, patient education programmes and nationally recognised fungal diagnostics.

This article provides an overview of how NAC supports both patients and healthcare professionals in the diagnosis and management of Chronic Pulmonary Aspergillosis.

"The National Aspergillosis Centre exists not only to care for patients with Chronic Pulmonary Aspergillosis, but also to support healthcare professionals throughout the UK in diagnosing and managing this complex condition."

Contents

Why specialist support matters

Chronic Pulmonary Aspergillosis (CPA) is a serious fungal lung disease that can develop in people with pre-existing respiratory conditions including bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), previous tuberculosis, sarcoidosis and other structural lung diseases.

Patients may present with chronic cough, breathlessness, fatigue, weight loss, recurrent chest infections or haemoptysis. These symptoms frequently overlap with more common respiratory conditions, making diagnosis challenging.

CPA remains a relatively uncommon disease and many clinicians may encounter only a small number of cases during their careers. As a result, specialist support can be valuable when diagnosis is uncertain, investigations are difficult to interpret or treatment becomes complex.

The National Aspergillosis Centre was established to provide that support.

What does the National Aspergillosis Centre do?

NAC is commissioned by NHS England to provide highly specialised care for patients with Chronic Pulmonary Aspergillosis.

The service supports patients through:

  • Specialist assessment and diagnosis
  • Multidisciplinary review of complex cases
  • Long-term disease monitoring
  • Antifungal treatment planning and optimisation
  • Therapeutic drug monitoring
  • Assessment and management of antifungal resistance
  • Management of drug interactions and adverse effects
  • Specialist physiotherapy support
  • Specialist nursing support
  • Access to clinical research and trials

Every new CPA diagnosis is reviewed within a specialist multidisciplinary team, helping to ensure a consistent and evidence-based approach to diagnosis and management.

NAC in 2023–24

  • 209 referrals assessed for aspergillosis
  • 101 new confirmed CPA diagnoses
  • 311 patients under active specialist follow-up
  • 71 external cases discussed through the National MDT
  • 56 remote advice and guidance consultations

Working with local teams

One of the most common misconceptions about referral is that patients must transfer all of their care to Manchester.

In reality, NAC operates primarily through a shared-care model.

Wherever possible, investigations, imaging, monitoring and routine care are organised locally, with NAC providing specialist input and treatment recommendations. This approach allows patients to benefit from national expertise while remaining close to home.

The service also supports healthcare professionals through remote advice, specialist consultation and participation in the National Multidisciplinary Team (MDT) meeting.

For many clinicians, discussing a case through the MDT can help clarify diagnosis, identify additional investigations and support treatment decisions before or alongside formal referral.

Benefits for patients

Patients referred to NAC gain access to one of the world's largest specialist CPA services.

Benefits include:

  • Specialist review by clinicians with extensive experience in fungal lung disease
  • Diagnostic clarification and confirmation
  • Optimisation of antifungal therapy
  • Management of treatment-related complications
  • Access to specialist physiotherapy and nursing support
  • Educational resources and self-management support
  • Opportunities to participate in research

For many patients, specialist review provides reassurance, a clearer understanding of their condition and confidence in their treatment plan.

Benefits for healthcare professionals

The National Aspergillosis Centre exists not only to support patients, but also to support healthcare professionals.

Referral or specialist discussion may be particularly useful when:

  • The diagnosis remains uncertain
  • Radiological findings are difficult to interpret
  • Patients are not responding as expected
  • Antifungal toxicity develops
  • Resistance is suspected
  • A specialist second opinion would be valuable

Clinicians also gain access to expertise in therapeutic drug monitoring, antifungal stewardship, complex fungal diagnostics and long-term disease management.

Each referral creates opportunities for shared learning, helping local teams build experience and confidence in recognising and managing aspergillosis.

Patient support and education

One of the most distinctive features of the National Aspergillosis Centre is the support available beyond routine clinical care.

Many patients referred to NAC have experienced a long and sometimes frustrating journey to diagnosis. Symptoms may have been present for months or years before Chronic Pulmonary Aspergillosis is recognised.

Following diagnosis, patients are often faced with an unfamiliar condition and may encounter alarming information online that relates to very different forms of aspergillosis. It is therefore common for patients and families to feel anxious, isolated and uncertain about what the future may hold.

For this reason, patient support forms an important part of the NAC service.

Through the Community, Awareness, Research, Education and Support (CARES) programme, patients have access to:

  • Regular patient support meetings
  • Educational webinars and presentations
  • Health and wellbeing sessions
  • Patient newsletters
  • Online information resources
  • The Aspergillosis Patients and Carers website
  • Peer support opportunities

One of the most common comments from newly diagnosed patients is the relief of discovering that they are not facing the condition alone. Meeting others living with aspergillosis and having access to trusted information can make a significant difference to confidence, understanding and long-term self-management.

"For many patients, finding the CARES programme is the moment they realise they are no longer facing aspergillosis on their own."

By combining specialist clinical care with education, support and community, NAC aims to help patients and families feel informed, supported and empowered throughout their journey.

Research, education and innovation

The National Aspergillosis Centre works closely with the Mycology Reference Centre Manchester (MRCM), one of Europe's leading specialist fungal diagnostic laboratories.

Together, NAC and MRCM contribute to:

  • Clinical trials of new antifungal therapies
  • Development of new diagnostic techniques
  • Antifungal resistance surveillance
  • National and international clinical guidelines
  • Professional education and training
  • Patient-centred research

The partnership has been recognised internationally through European Confederation of Medical Mycology (ECMM) Diamond Centre of Excellence status.

This close integration of clinical care, diagnostics, education and research helps ensure that patients benefit from the latest developments in fungal disease management.

Why awareness still matters

Chronic Pulmonary Aspergillosis remains an under-recognised disease worldwide.

Many patients present with symptoms that overlap with more common respiratory conditions such as COPD, bronchiectasis or previous tuberculosis. As a result, diagnosis can sometimes be delayed or missed.

This is not because clinicians are failing. CPA is an uncommon disease that can closely resemble more familiar respiratory conditions.

The role of NAC is therefore not simply to provide specialist treatment, but also to support earlier recognition of CPA through education, diagnostic support and collaborative working with healthcare professionals throughout the UK.

By raising awareness and improving access to specialist expertise, we hope to help more patients receive timely diagnosis, appropriate treatment and long-term support.

Further resources

Working together

The National Aspergillosis Centre was established to ensure that patients with Chronic Pulmonary Aspergillosis have access to specialist expertise wherever they live.

Through shared-care working, multidisciplinary collaboration, specialist diagnostics, patient support, education and research, NAC continues to work alongside healthcare professionals throughout the UK to improve outcomes for people living with fungal lung disease.

Whether through referral, multidisciplinary discussion, specialist advice or educational resources, our aim remains the same: helping clinicians diagnose and manage aspergillosis with confidence while ensuring patients receive the support they need.

NAC is more than a referral centre. It is a national resource for patients, clinicians and healthcare services working together to improve the diagnosis and management of Chronic Pulmonary Aspergillosis.

by GAtherton

Illustration showing an aspergillosis patient health summary, myMFT patient portal, steroid emergency card, NHS number card and inhaler, highlighting the key medical information patients should carry for emergency and routine healthcare.

Do You Carry Your Aspergillosis Information With You?

Illustration showing an aspergillosis patient health summary, myMFT patient portal, steroid emergency card, NHS number card and inhaler, highlighting the key medical information patients should carry for emergency and routine healthcare.
A simple one-page health summary can help healthcare professionals quickly understand an aspergillosis patient's diagnosis, medications, allergies and specialist care requirements.

New NHS Plans Could Help in Future – But What About Today?

The UK government is currently debating plans for a new NHS “single patient record” system. The aim is to allow authorised healthcare professionals to access important information from GP surgeries, hospitals, community services and other parts of the NHS more easily.

If implemented successfully, this could reduce the need for patients to repeatedly explain their medical history and could help emergency departments, ambulance crews and other healthcare professionals see important information such as diagnoses, medications, allergies and previous treatment.

For people living with aspergillosis and other long-term respiratory conditions, this could be especially valuable. However, these changes will take time to develop and introduce. For now, patients remain one of the most important links between different parts of the healthcare system.

Why This Matters for Aspergillosis Patients

Many people with aspergillosis receive care from several different services, including:

  • General Practitioners (GPs)
  • Local respiratory teams
  • Specialist nurses
  • Hospital clinics
  • Emergency departments
  • Pharmacists
  • Community healthcare teams
  • Specialist centres such as the National Aspergillosis Centre

Healthcare records are not always immediately available to every professional involved in your care. This means there may be times when you need to explain:

  • What type of aspergillosis you have
  • Which medications you take
  • Any important allergies or serious drug reactions
  • Whether you have adrenal insufficiency or take long-term steroids
  • Who your specialist team is
  • What previous treatments you have received

Having this information readily available can save time and may help healthcare professionals make decisions more quickly and safely.

What Information Should You Carry?

You do not need to carry your entire medical record. A simple one-page health summary is usually enough.

1. Your Diagnosis

List your main diagnoses clearly. Examples include:

  • Allergic Bronchopulmonary Aspergillosis (ABPA)
  • Chronic Pulmonary Aspergillosis (CPA)
  • Severe Asthma with Fungal Sensitisation (SAFS)
  • Aspergillus Bronchitis
  • Bronchiectasis
  • Severe Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

2. Your Current Medications

Include all current treatments, particularly:

  • Antifungal medications, such as itraconazole, voriconazole, posaconazole or isavuconazole
  • Steroid tablets
  • Hydrocortisone replacement therapy
  • Biologic therapies
  • Inhalers
  • Oxygen therapy
  • Antibiotics you are currently taking

Try to keep this list up to date.

3. Drug Allergies and Serious Reactions

This is one of the most important sections. Include any known allergies or serious reactions, for example:

  • Penicillin allergy
  • Prednisolone allergy
  • Previous severe drug reactions
  • Medicines you have been told to avoid

4. Steroid or Adrenal Information

If you have adrenal insufficiency or are taking long-term steroid treatment, make this very clear.

I have adrenal insufficiency and may require emergency steroid treatment if seriously unwell.

Many patients already carry a steroid emergency card. If you have been advised to carry one, continue to carry it at all times.

5. Specialist Contact Information

Include:

  • Consultant name
  • Hospital or specialist centre
  • Clinic or specialist nurse contact details, if available

6. Emergency Contact

Include:

  • Name
  • Relationship
  • Telephone number

An Important Extra Note for Aspergillosis Patients

Many antifungal medications interact with other medicines. If you take itraconazole, voriconazole, posaconazole or isavuconazole, consider including the following statement on your health summary:

I take an azole antifungal medication. Please check for potential drug interactions before prescribing new medicines.

This simple statement may help avoid medication-related problems.

If You Are a National Aspergillosis Centre Patient: Using myMFT

If you are a patient of the National Aspergillosis Centre (NAC), you may already have access to some of your hospital information through the myMFT patient portal.

myMFT is the patient portal used by Manchester University NHS Foundation Trust (MFT), which includes Wythenshawe Hospital and the National Aspergillosis Centre.

Depending on the services you use, myMFT may allow you to:

  • View MFT appointment details
  • Access clinic letters
  • Keep track of important test results, letters and health information
  • Attend online video consultations
  • Use proxy access to help manage a family member’s healthcare, with consent

Many patients find it useful to keep copies of important clinic letters on their phone or tablet. This can be particularly helpful if you attend another hospital, visit your GP, travel away from home or need emergency treatment.

myMFT does not replace a future NHS-wide patient record, but it can provide access to important information that may help you and your healthcare professionals manage your care more effectively.

Find out more about myMFT on the Manchester University NHS Foundation Trust website.

For Patients Not Under the National Aspergillosis Centre

If you are not an NAC or MFT patient, your local hospital may have its own patient portal or online record system. Ask your hospital clinic, respiratory team or GP surgery whether you can access clinic letters, appointment information or test results online.

You may also be able to use the NHS App to manage parts of your healthcare, depending on your GP surgery and local NHS services.

Find out more about the NHS App.

You may also find it useful to know your NHS number. You do not need to know your NHS number to receive NHS care, but it can be helpful when contacting services or completing forms.

Find your NHS number.

Where Should You Keep Your Information?

Many patients choose to:

  • Save a copy on their mobile phone
  • Keep a printed copy in their wallet or handbag
  • Store it alongside their steroid emergency card
  • Keep a copy with travel documents
  • Share a copy with family members or carers
  • Keep copies of important clinic letters on their phone or tablet

The best system is the one that is easy to access when needed.

Printable options (Word documents):

Looking Ahead

The proposed NHS single patient record could eventually make it easier for healthcare professionals to access important information quickly and safely.

For patients with rare conditions such as aspergillosis, that could improve continuity of care, reduce delays and reduce the need to repeatedly explain complex medical histories.

Until then, carrying a simple summary of your condition remains one of the easiest and most effective ways to help healthcare professionals understand your health needs and provide appropriate care.

Key Points

  • Carry a simple one-page health summary.
  • Include diagnoses, medications, allergies and specialist contacts.
  • Clearly state if you have adrenal insufficiency or take long-term steroids.
  • Mention azole antifungal treatment and potential drug interactions.
  • National Aspergillosis Centre patients may be able to access clinic information through myMFT.
  • Patients outside MFT should ask whether their own hospital has a patient portal.
  • Keep important information on your phone and consider carrying a printed copy.
  • A future NHS single patient record may improve information sharing, but patients remain an important source of information today.

Common Questions

Do I need to carry all my clinic letters?

No. A concise one-page summary is usually more useful in an emergency. However, keeping copies of important clinic letters on your phone can be helpful.

What if I am treated at more than one hospital?

This is one of the main reasons to carry a health summary. Different healthcare providers may not always have immediate access to the same information.

Is this only useful in emergencies?

No. It can also help during GP appointments, outpatient visits, travel, planned hospital admissions and when seeing healthcare professionals unfamiliar with aspergillosis.

What if I am a National Aspergillosis Centre patient?

Consider registering for myMFT and keeping important clinic letters available on your phone or tablet for easy access.

What if I am not an NAC patient?

Ask your own hospital or respiratory clinic whether they offer a patient portal. You can also check what information is available through the NHS App.

When to Seek Medical Advice

Seek urgent medical advice if you experience:

  • Significant worsening of breathlessness
  • Chest pain
  • Coughing up significant amounts of blood
  • Symptoms of adrenal crisis if you have adrenal insufficiency
  • Severe allergic reactions to medications
  • Rapid deterioration in your respiratory symptoms

If you need emergency help, call 999. For urgent medical advice in the UK, use NHS 111.

Useful Links

Frequently Asked Questions

What information should an aspergillosis patient carry in an emergency?

Patients should consider carrying a summary of their diagnosis, medications, allergies, steroid or adrenal information, specialist contacts and emergency contact details.

Should people with aspergillosis carry a medication list?

Yes. Many aspergillosis patients take antifungal medicines, steroids, biologic therapies and inhalers. An up-to-date medication list can help avoid prescribing errors and drug interactions.

What is myMFT?

myMFT is the patient portal used by Manchester University NHS Foundation Trust. It allows eligible patients to access appointments, clinic letters, test results and other healthcare information.

Can aspergillosis patients access their records online?

Some patients can access records through services such as myMFT, local hospital portals or the NHS App, depending on where they receive care.

What is the NHS single patient record?

The proposed NHS single patient record aims to improve information sharing between healthcare providers so patients do not need to repeatedly explain their medical history.

Author: National Aspergillosis Centre Patient Support Team

Reviewed by: National Aspergillosis Centre

Last reviewed: June 2026

Important: This article is intended for information only and should not replace advice from your healthcare team.

by GAtherton

Infographic showing how the UK infection workforce report could improve aspergillosis diagnosis, fungal specialist care, digital health and patient outcomes

What the UK Infection Workforce Report Means for Aspergillosis Patients and Specialists

Infographic showing how the UK infection workforce report could improve aspergillosis diagnosis, fungal specialist care, digital health and patient outcomes
The new UK infection-specialist workforce report highlights the growing importance of fungal disease expertise, specialist diagnostics and networked aspergillosis care.

Summary: A major new UK infection-specialist workforce report recognises fungal disease expertise as an essential part of modern healthcare. The report has important implications for aspergillosis diagnosis, specialist services, digital care, antifungal stewardship and future workforce planning.

Key points

  • Medical mycology is now recognised as part of essential UK infection infrastructure.
  • Rising immunosuppression and chronic lung disease are increasing demand for aspergillosis expertise.
  • The report supports networked specialist care, closely matching the National Aspergillosis Centre model.
  • Advanced fungal diagnostics and specialist interpretation are increasingly important.
  • Digital and community-based care could improve access for patients living far from specialist centres.
  • Antifungal stewardship and resistance monitoring are likely to become much more prominent.

Why was this report produced?

This report was produced in 2026 by a coalition of the UK’s leading infection societies, including organisations representing infectious diseases physicians, microbiologists, virologists, infection prevention specialists, pharmacists, laboratory scientists and medical mycologists.

It reflects growing concern that the UK infection-specialist workforce is under increasing strain at a time when infectious diseases are becoming more complex, more resistant to treatment and more internationally connected.

The report was produced in response to several major pressures affecting the NHS and wider healthcare system:

  • the long-term impact of the COVID-19 pandemic;
  • rising antimicrobial resistance (AMR);
  • an ageing population with more chronic disease;
  • increasing use of immunosuppressive medicines, biologics and transplantation;
  • workforce shortages in infection specialties;
  • concerns about future pandemics and emerging infections;
  • growing demand for complex diagnostics and specialist infection advice;
  • the NHS shift toward community and digitally enabled care.

The report also aligns closely with the NHS 10-Year Plan and wider UK health-security planning. It repeatedly refers to the need for three major shifts in healthcare delivery:

  • moving care from hospital to community;
  • shifting from reacting to illness toward prevention;
  • accelerating digital and data-driven healthcare systems.

Importantly for aspergillosis and fungal disease, the report recognises that modern infection medicine now extends far beyond traditional bacterial infections. Infection specialists are increasingly dealing with:

  • complex fungal infections;
  • drug-resistant organisms;
  • infections linked to immunosuppression;
  • global travel and climate change;
  • high-risk vulnerable patients;
  • and emerging pathogens.

The report can therefore be seen as both:

  1. a warning that infection services are under significant pressure and risk workforce shortages; and
  2. a strategic argument for greater investment in specialist infection expertise, diagnostics, digital infrastructure and networked care.

For aspergillosis specialists, one of the most important aspects is that medical mycology and fungal diagnostics are now being recognised as part of essential national infection infrastructure rather than as peripheral specialist services.

In many ways, the report reflects lessons learned during the COVID-19 pandemic. During COVID, the NHS saw how rapidly infection services, diagnostics, surveillance systems and specialist expertise became critical to national resilience. The experience also highlighted how vulnerable immunocompromised patients are to opportunistic infections, including fungal disease such as COVID-associated pulmonary aspergillosis (CAPA).

The report therefore represents a broader move toward building a more resilient, better-connected and more prevention-focused infection system for the future.

1. Fungal disease expertise is recognised as core infection infrastructure

One of the most significant implications is that the report explicitly includes mycologists and fungal diagnostics specialists within the UK infection-specialist workforce.

This matters because fungal disease services have often been under-recognised compared with bacterial and viral infection services. For aspergillosis specialists, the report strengthens the argument that medical mycology is not a niche extra, but a necessary part of safe, modern infection care.

For patients, this recognition may help support better access to specialist fungal expertise, particularly for complex conditions such as chronic pulmonary aspergillosis (CPA), allergic bronchopulmonary aspergillosis (ABPA) and invasive aspergillosis.

2. Aspergillosis is likely to become more important

The report highlights several pressures on infection services, including ageing populations, multi-morbidity and increasing use of immunosuppressive treatments. These are also major risk factors for Aspergillus-related disease.

This means clinicians may see increasing numbers of patients with:

  • chronic pulmonary aspergillosis (CPA);
  • invasive aspergillosis;
  • Aspergillus disease in bronchiectasis;
  • Aspergillus complications in people receiving biologics, chemotherapy or transplant medicines;
  • azole-resistant Aspergillus infections.

For patients, this could eventually mean better awareness and diagnosis. However, unless the specialist workforce grows, increased recognition may also place more pressure on already stretched fungal services.

3. The report supports networked specialist care

The report strongly supports regional and national specialist networks, shared expertise, multidisciplinary team working and digital advice models.

This is highly relevant to aspergillosis. Many patients are looked after locally by respiratory, microbiology or infectious diseases teams, but need input from specialist fungal centres for diagnosis, treatment decisions and monitoring.

This supports a model where local teams remain involved, but have rapid access to national fungal expertise when needed.

4. Diagnostics are central to better aspergillosis care

Aspergillosis is often difficult to diagnose. Test results need careful interpretation because Aspergillus can represent colonisation, allergy, chronic infection or invasive disease depending on the clinical context.

The report’s focus on rapid diagnostics, molecular testing, genomics, digital laboratory systems and expert interpretation is therefore highly relevant.

For aspergillosis, improved diagnostic pathways could include better access to:

  • Aspergillus immunoglobulin G (IgG);
  • Aspergillus immunoglobulin E (IgE);
  • galactomannan testing;
  • fungal polymerase chain reaction (PCR);
  • azole resistance testing;
  • fungal culture and sequencing;
  • specialist radiology review.

For patients, this could mean fewer missed diagnoses, shorter diagnostic delays and more personalised treatment.

5. Community and digital care could help patients

The report supports moving appropriate care closer to home, using outpatient antimicrobial therapy, virtual services and digitally enabled community pathways.

For people with aspergillosis, this could be very beneficial. Many patients have long-term breathlessness, fatigue and mobility limitations, and may live far from specialist centres.

Potential benefits include:

  • fewer long-distance hospital visits;
  • remote monitoring of symptoms and test results;
  • shared-care arrangements with local hospitals;
  • virtual multidisciplinary team review;
  • faster specialist advice for local clinicians.

However, fungal disease management is complex. Community pathways must still include specialist oversight because antifungal treatment can involve drug interactions, liver toxicity, therapeutic drug monitoring, adrenal suppression and resistance issues.

6. Antifungal stewardship should become more prominent

The report focuses heavily on antimicrobial stewardship. Although much of this is framed around antibiotics, the same principles apply to antifungal medicines.

For aspergillosis care, antifungal stewardship means using the right antifungal, at the right dose, for the right duration, with careful monitoring.

This is especially important because of:

  • azole resistance in Aspergillus fumigatus;
  • long courses of antifungal treatment;
  • drug interactions with steroids, anticoagulants, immunosuppressants and other medicines;
  • the need for therapeutic drug monitoring;
  • side effects affecting the liver, skin, nerves or adrenal system.

For patients, better antifungal stewardship should mean safer and more effective treatment.

7. Fungal disease has a role in pandemic preparedness

The report includes mycology within pandemic preparedness planning. This is important because fungal complications can emerge during major respiratory outbreaks.

COVID-associated pulmonary aspergillosis (CAPA) showed that fungal disease can become highly relevant during pandemics, especially in intensive care and immunocompromised patients.

Future preparedness should therefore include fungal diagnostics, fungal surveillance, resistance monitoring and specialist mycology input.

8. Workforce expansion is essential

The report warns that the infection-specialist workforce is under pressure. This is particularly important for fungal disease because the UK has a limited number of specialist medical mycologists, fungal pharmacists, laboratory scientists and specialist nurses.

For aspergillosis services, workforce planning should include:

  • more medical mycology training opportunities;
  • more specialist fungal pharmacists;
  • more fungal diagnostics scientists;
  • more specialist nurses supporting long-term fungal disease care;
  • protected time for multidisciplinary team meetings and advice services.

Without this, diagnostic delays and unequal access to specialist care may persist.

9. What this means for patients

For patients, the report supports several important messages:

  • fungal disease expertise matters;
  • specialist diagnosis and treatment are important;
  • long-term fungal lung disease requires joined-up care;
  • access to expert advice should not depend too heavily on postcode;
  • digital and shared-care systems could reduce the need for repeated travel;
  • patient education should be part of infection service planning.

The report may also be useful for patient advocacy because it provides national-level support for strengthening infection services, including fungal infection expertise.

10. What is still missing?

Although the report is very helpful, aspergillosis itself is not discussed in detail. Areas that would benefit from stronger future emphasis include:

  • chronic pulmonary aspergillosis (CPA);
  • allergic bronchopulmonary aspergillosis (ABPA);
  • severe asthma with fungal sensitisation (SAFS);
  • Aspergillus bronchitis;
  • azole-resistant Aspergillus;
  • environmental mould exposure and health;
  • long-term patient support and rehabilitation.

This creates an opportunity for aspergillosis specialists, patient groups and charities to build on the report and make the case for more visible fungal disease planning.

Conclusion

This report is a positive development for aspergillosis. It recognises that fungal disease expertise is part of the UK’s essential infection workforce and supports many of the changes aspergillosis patients need: better diagnostics, stronger specialist networks, digital care, community support, workforce expansion and safer antimicrobial use.

The key challenge is ensuring that fungal disease does not remain only briefly mentioned within broader infection policy. Aspergillosis specialists and patient advocates can use this report to argue that fungal infection services need sustained investment, national planning and equitable access across the UK.

by GAtherton

Can overseas patients access specialist centres like NAC? A clear guide for patients and families

Last reviewed: April 2026

Key points

  • Specialist centres such as the National Aspergillosis Centre (NAC) cannot provide individual medical advice directly to patients, especially from overseas.
  • This is due to safety, legal, and clinical responsibility requirements.
  • The correct route is through a local doctor, using a formal referral process.
  • A referral does not guarantee that a patient will be seen.
  • Even when doctors contact specialist centres, there are limits to what can be offered.
  • NAC does not offer private care, although some other centres do.

Table of contents

Why can’t specialist centres respond directly to patients?

It is natural to want to contact a specialist centre directly, especially when dealing with a complex condition such as aspergillosis. However, centres like NAC cannot provide individual medical advice directly to patients.

This is not a matter of choice—it is because they cannot safely or legally do so.

Patient safety

  • Safe medical advice requires full access to medical records, test results, and examination findings
  • Doctors must be able to monitor progress and adjust treatment
  • This cannot be done through messages or emails alone

Legal and regulatory requirements

  • Doctors must follow strict rules set by regulators such as the General Medical Council (GMC) in the UK
  • They cannot take responsibility for a patient without a formal clinical relationship

Responsibility for care

  • Any doctor giving advice must be able to take responsibility for outcomes
  • This requires recognised clinical pathways and follow-up arrangements

In summary: Specialist centres are not refusing help—they cannot provide care outside safe and regulated systems.

The correct way to get help

The safest and most effective way to access specialist expertise is through your local doctor.

Step 1 – See a local specialist

  • Respiratory doctor
  • Infectious disease specialist
  • Internal medicine specialist

Step 2 – Assessment and initial care

  • Your doctor reviews your symptoms and history
  • Tests are arranged where needed
  • Treatment may be started

Step 3 – Referral or specialist advice

This approach ensures your care is coordinated, safe, and based on full clinical information.

What does a referral mean?

A referral is when your doctor formally asks another specialist or centre to review your case or consider seeing you.

This is not just a message—it is a structured clinical process.

What does a referral usually include?

  • Your medical history
  • Details of your symptoms
  • Results of tests (such as scans or laboratory results)
  • Treatments you have already received
  • A clear reason for referral

This allows the specialist centre to understand your situation safely and properly.

What happens next?

After reviewing the referral, the specialist centre may:

  • ✔️ Accept the referral and arrange an appointment
  • ✔️ Provide advice to your doctor without seeing you
  • ✔️ Suggest a more appropriate service
  • ❌ Decline the referral

A referral is like a formal handover between doctors—it does not guarantee an appointment.

Will a referral always be accepted?

Even when your doctor makes a referral, it is important to understand that the referral may not always be accepted.

Why might a referral not be accepted?

Eligibility criteria

  • Specialist centres often have strict criteria for the patients they can see
  • Some services are commissioned only for specific conditions

Geographic and funding rules

  • Access may depend on healthcare system or funding arrangements

Clinical suitability

  • The centre may decide your care can be managed locally
  • They may offer advice instead of accepting the referral

Capacity

  • Specialist centres often manage large numbers of complex patients

What happens if it is not accepted?

  • Your doctor may still receive expert advice
  • You may be directed to another service
  • Your care continues locally

This does not mean you are being refused help.

Why specialist centres may not be able to confirm anything to you

Patients and families sometimes ask a specialist centre whether a referral has been received, reviewed, or accepted.

It is important to understand that the centre may not be able to confirm or discuss this with you directly.

Why is this?

Confidentiality and data protection

  • Medical information is protected by strict confidentiality rules
  • In the UK, this includes laws such as data protection legislation and professional duties of confidentiality
  • Centres must be certain they are communicating with the correct person and through approved channels

Communication is usually between doctors

  • Referrals are handled as clinician-to-clinician communication
  • Responses are normally sent back to the referring doctor, not directly to the patient

No confirmation does not mean no action

  • If you do not receive a reply from the centre, it does not necessarily mean your referral has been ignored
  • Advice or decisions may already have been communicated to your doctor

What should you do?

  • Contact your own doctor for updates
  • Ask whether a referral has been sent and if a response has been received
  • Discuss next steps with your clinical team

Summary

Specialist centres usually communicate with your doctor, not directly with patients. This is to protect your privacy and ensure safe, appropriate communication.

Do personal requests from patients or families help?

Personal requests are completely understandable, but specialist centres cannot provide individual medical advice directly to patients, even in urgent situations.

This is because they cannot safely or legally do so without a doctor involved.

These requests may still help with general information and guidance, but they do not usually lead to diagnosis or treatment advice.

Limits even when doctors are involved

When your doctor contacts a specialist centre, this is the correct route—but there are still limits.

What specialist centres can offer

  • Expert opinion
  • Suggestions for diagnosis
  • Guidance on tests
  • Interpretation of results

What they cannot usually provide

  • Direct patient care
  • Full responsibility for treatment
  • Definitive diagnosis without full assessment

Your local doctor remains responsible for your care.

What about private care?

The National Aspergillosis Centre (NAC) does not offer private care.

  • You cannot arrange to be seen there privately
  • Access is through NHS referral pathways only

Some other specialist centres may offer private consultations. However:

  • A referral and medical records are usually required
  • An in-person assessment is typically needed
  • Private care does not bypass safety or legal requirements

Common myths

  • “I can contact a specialist centre directly for help”
    → Centres cannot provide individual advice directly to patients
  • “If it’s urgent, they will make an exception”
    → The same safety rules apply to all patients
  • “A referral guarantees I will be seen”
    → Referrals are reviewed and may not always be accepted
  • “Private care means I can be seen anywhere”
    → Not all centres offer private care (NAC does not)
  • “A detailed email is enough for diagnosis”
    → Diagnosis requires full clinical assessment

When to seek urgent medical help

If you or someone you care for has any of the following, seek urgent local medical care:

  • Severe breathlessness
  • Chest pain
  • Coughing up blood
  • Confusion or extreme drowsiness
  • High fever that is not improving

Do not delay seeking help while trying to contact overseas specialists.

Summary

Specialist centres such as NAC play an important role in supporting complex conditions like aspergillosis. However, they must work within systems designed to keep patients safe.

The most effective way to access their expertise is through your own doctor, using formal referral pathways and specialist advice where needed.

Author & review information

Prepared for patient education purposes.
Aligned with UK specialist centre practice and patient safety guidance.

References & further reading

by GAtherton

Help shape the future of aspergillosis care across Uk & Europe

Many people living with aspergillosis, and many carers, reach a point where they ask:

“Can patients do more than just cope with this condition?”

The answer is yes.

The European Lung Foundation (ELF)
and its
Aspergillosis Patient Advisory Group (PAG)
give patients and carers a chance to contribute to something bigger: better awareness, better information, better research, and better care.

What is ELF?

ELF is a Europe-wide organisation that brings patients, carers, healthcare professionals and researchers together to improve lung health information, treatment and care.

One of ELF’s strongest advantages is that it works across Europe, not just in one country. It also makes key information available in several languages, helping more people access reliable information about lung conditions, including aspergillosis.

You can read ELF’s patient information on aspergillosis here:
Aspergillosis – European Lung Foundation.

What is the Aspergillosis Patient Advisory Group?

The Aspergillosis PAG is part of ELF’s wider network of
Patient Advisory Groups.
These groups bring together people with experience of specific lung conditions, or experience as carers, so that patient views can help improve treatment and healthcare.

The Aspergillosis PAG works to raise awareness of aspergillosis and improve diagnosis, treatment and care. It also works alongside healthcare professionals and researchers involved in the Chronic Pulmonary Aspergillosis Network (CPAnet), helping identify research priorities and information gaps for both patients and professionals.

Why does this matter?

Aspergillosis is still not well understood in many places. Diagnosis can be delayed, information can be hard to find, and patients often feel that few people truly understand what living with the condition is like.

By involving patients and carers directly, ELF helps ensure that real-life experience is not left out of the conversation. This can influence education, awareness work, research priorities and wider discussions about care across Europe.

What is in it for the patient or carer?

This is an important question, because volunteering your time and energy is a big ask, especially when you are already managing illness, fatigue, appointments, uncertainty or caring responsibilities.

So it is only fair to be clear and honest about what people may gain from taking part.

1. A chance to make your experience count

Many people with aspergillosis have learned difficult lessons the hard way. Getting involved gives you a chance to turn that experience into something useful — helping improve information, shape priorities and make life a little easier for future patients.

2. Better understanding and confidence

Being involved can help you better understand how research, awareness work and patient representation operate. Some people find that this gives them more confidence when speaking about their condition and navigating their own care.

3. Connection beyond your local area

Because ELF is Europe-wide, patients are not limited to the perspective of one hospital, one region or one country. For people living with a relatively uncommon condition, that wider connection can feel valuable and reassuring.

4. The opportunity to be heard

Many patients are used to feeling overlooked. PAGs are designed so that patient and carer perspectives are actively included in projects and discussions, rather than being an afterthought.

5. A sense of purpose

Some people find that involvement helps them move from simply living with a difficult condition to doing something constructive with that experience. It will not suit everyone, but for some it can be meaningful.

6. Support and training

ELF says it provides support, guidance and training to help people share their perspective and get involved in projects. It also encourages interested patients and carers to use its free online European Patient Ambassador Programme (EPAP), which introduces the skills and knowledge needed to represent yourself and others effectively.

What it is not

It is also important to be realistic.

  • It is not medical care.
  • It does not replace your doctor, nurse or specialist team.
  • It is not a route to faster treatment.
  • It is not a paid role.

ELF states that PAG involvement is voluntary and that it is unable to pay for people’s time.

Who can join?

ELF says most PAGs are open to new members from European countries. In general, people are invited to get involved if they are over 18, have experience as a patient or carer, live in a European country, can communicate in English, are interested in improving healthcare and treatment across Europe, and are willing to share their perspective.

That said, this should not feel like an all-or-nothing commitment. Not everyone can give a lot of time, and health can change. Even modest involvement can still be worthwhile.

Why mention this to our groups?

Many people in aspergillosis support communities have exactly the kind of insight that is valuable here: the reality of diagnosis, treatment, daily management, side effects, uncertainty, isolation, and learning how to cope.

Those experiences matter. They can help improve what is researched, what is explained, and how future patients are supported.

Interested?

You can explore more here:

You do not need to be an expert. You do not need to be highly confident. You do not need to commit to everything.

But if you have lived with aspergillosis, or cared for someone who has, your experience may be more valuable than you think.

In short: this is a voluntary opportunity to help improve understanding, research and care for aspergillosis across Europe, while connecting with a wider patient community and making sure lived experience is heard.

by GAtherton

Why do doctors ask me to repeat my history — and sometimes not read my summary?

Last reviewed: 9 April 2026

Many patients, especially those with long-term or complex health problems, say the same thing: “Why do I always have to repeat everything?” Some also say that even when they bring a short written summary, it is put to one side and does not seem to be read straight away.

This can feel frustrating, tiring, and dismissive. In most cases, though, it is not because the doctor does not care. It is usually because of how medical appointments are structured, how clinicians are trained, and the time pressures built into the healthcare system.

This article explains what may be happening, why doctors often work this way, and what can sometimes help patients get more out of appointments.

Key points

  • Doctors are usually not ignoring you or your efforts.
  • They are trained to hear the story directly from the patient for safety and accuracy.
  • Medical notes can be long, incomplete, hard to access quickly, or spread across different systems.
  • A written summary can still be helpful, but it may work best as a support tool rather than a replacement for discussion.
  • The system is often particularly difficult for people with complex, long-term conditions.

Contents

Why do doctors ask patients to repeat information?

Many patients assume that if something is already in the notes, the doctor should simply read it and move on. In practice, clinicians are usually taught not to rely only on previous notes. They are expected to take a current history directly from the patient wherever possible.

1. They need a fresh history

Symptoms can change. A note written last week, last month, or even earlier the same day may no longer fully reflect what is happening now. A doctor needs to understand the present situation, not just the recorded one.

This matters because:

  • new symptoms may have appeared
  • older symptoms may have improved or worsened
  • important details may have been left out of earlier notes
  • previous notes can sometimes contain misunderstandings or errors

2. Hearing the story directly is part of diagnosis

Doctors do not just collect facts. They also listen to how symptoms are described, what concerns the patient most, what order things happened in, and whether there are any clues that do not fit the previous record.

For example, hearing a patient say “this is much worse than usual” or “the pain has changed completely” may matter just as much as what is already written down.

3. Each clinician is responsible for their own decisions

Every doctor is professionally responsible for the decisions they make in that consultation. Because of that, they usually need to confirm the key information for themselves rather than relying entirely on another person’s notes or summary.

4. Notes are not always as clear or complete as patients imagine

Patients often assume the notes tell the whole story. Sometimes they do not. They may be brief, scattered across different entries, missing key context, or written in a way that does not quickly explain the current problem.

Why might a written summary be set aside?

Patients who have made the effort to prepare a summary can feel especially upset when a doctor places it to one side. It may look like the document is being ignored. Often, however, the doctor is following a routine approach to consultation rather than rejecting the information.

1. Many consultations follow a familiar structure

Doctors are often trained to work in a rough sequence:

  1. listen to the patient’s account
  2. ask follow-up questions
  3. clarify the current concern
  4. review supporting information and records
  5. decide what to do next

So a written summary handed over at the start may be used later, not immediately.

2. They may not want the written summary to shape their thinking too early

Clinicians are often cautious about being overly influenced by somebody else’s wording before they have heard the patient directly. This is part of clinical reasoning and risk management. They may want to form their own understanding first, then compare it with the summary.

3. Reading while listening can be difficult

In a short appointment, a doctor may feel they cannot properly read a document, listen closely, ask questions, and maintain eye contact all at the same time. They may therefore choose to focus first on the conversation.

4. Some summaries are not easy to use quickly

Even a well-meant summary may be hard to absorb if it is too long, too detailed, or does not make the current issue obvious straight away. Doctors are often trying to answer one urgent question first:

What is the main problem today?

If that is not immediately clear from the page, they may return to direct questioning.

What are doctors trying to achieve?

From a patient’s point of view, repeating information can feel inefficient and unnecessary. From a clinician’s point of view, the consultation is often trying to achieve several things at once:

  • Accuracy: understanding what is happening now, not just what happened before
  • Safety: checking for changes, gaps, or warning signs
  • Clarity: identifying the most important issue for that appointment
  • Responsibility: making decisions based on information they have personally checked

That does not make the experience any less frustrating for patients, but it can help explain the behaviour.

Why is this harder for people with long-term conditions?

This problem is often worse for people who have:

  • complex diagnoses
  • multiple health conditions
  • long medical histories
  • many medications
  • appointments with different teams or hospitals

If you live with a chronic condition, you may have repeated the same history many times. You may also already be tired, breathless, in pain, stressed, or worried. In that situation, being asked again to explain everything can feel overwhelming.

This is a real systems problem. It is not a sign that you are failing to explain yourself properly, and it is not unreasonable to find it difficult.

What can help in appointments?

There is no perfect solution, but some approaches can make appointments easier and increase the chance that useful information is taken in.

Start with the main issue today

A helpful opening sentence can be:

“The main issue today is…”

This quickly gives the doctor a focus and may reduce the need to retell everything in full.

Keep written summaries short

A one-page summary is usually easier to use than a longer document. It can include:

  • main diagnoses
  • current medications
  • important recent events
  • relevant allergies or major problems
  • today’s main concern at the top

Offer the summary rather than relying on it

Instead of assuming it will be read immediately, it may help to say:

“I have brought a short summary in case it is useful.”

or:

“Would it help if I gave you a one-page summary of my background?”

This fits better with how many consultations flow.

Use the summary as a support tool

A written summary often works best as:

  • a memory aid for the patient
  • a quick reference for the doctor
  • a back-up in case important facts are missed

It may be less effective if used as a substitute for the whole conversation.

Say when repetition is difficult

If repeating your history is hard because of pain, fatigue, breathlessness, stress, memory problems, or the complexity of your condition, it is reasonable to say so politely.

“I’m happy to summarise, but I do find repeating the full history difficult.”

That can help the doctor understand the burden on you.

Common questions

Are doctors not reading my notes at all?

Sometimes they have read some of them, but not everything. Sometimes they have skimmed the record for key issues. Sometimes the most relevant information is hard to find quickly. The fact that they ask questions does not always mean they have read nothing.

Why do they not just read my summary instead of asking me?

Because they are usually expected to hear the current story directly, check the important facts for themselves, and understand what matters most right now.

Is there any point bringing a written summary?

Yes. A good summary can still be very helpful. It may save time, improve accuracy, and make it easier to communicate complex information. It is just not always used in the way patients expect.

Does putting my summary to one side mean it has been ignored?

Not necessarily. It may be read later in the appointment, after the consultation, or used as a reference rather than read word for word in front of you.

When to seek further support

You may want more support if:

  • you repeatedly feel that important information is not being understood
  • your condition is complex and hard to explain in a short appointment
  • you feel too unwell or distressed to repeat your history each time
  • you think communication problems are affecting your care

Possible options include:

  • asking whether a clinic letter or care plan summary can be used
  • bringing a relative, friend, or advocate to appointments
  • keeping a short up-to-date medical summary with you
  • asking whether the main issue for that appointment can be agreed early on

Final thought

It can be upsetting to feel that your effort has been overlooked or that you are being asked to say the same things again and again. Usually, though, what you are seeing is not indifference but the way modern consultations are structured around safety, time pressure, and direct assessment.

Your summary is still worth bringing. The most useful expectation is often not that it will replace the conversation, but that it may support it.

Important note

This article is general educational information. It is not medical advice and cannot explain every individual consultation or healthcare setting.

Author and review information

Prepared as general patient information to help explain common experiences in healthcare appointments.

by GAtherton

Real Questions. Clear Answers. Practical Support for People Living with Aspergillosis.

If you live with aspergillosis, or support someone who does, you will know how many questions can come up between appointments. Some are about symptoms. Some are about treatment. Some are about day-to-day life, side effects, monitoring, damp, mould, travel, fatigue, anxiety, or simply trying to understand what is happening.

That is why we have built and continue to expand our Patient Questions & Latest Articles section.

This part of our website brings together detailed answers to the kinds of questions patients and carers actually ask. Many of these articles began as real questions raised in our support meetings and online communities, then developed into fuller explanations so that others could benefit too.

Why this section is useful

Living with aspergillosis often means having to manage a lot of uncertainty. Information can be difficult to find, hard to interpret, or scattered across different places. We wanted to create a space that is easier to use: a place where people can browse practical topics, explore recent articles, and find trustworthy explanations written with patients and carers in mind.

Some people arrive with one urgent question. Others simply want to browse and see whether someone else has already asked the same thing. This section is designed to help with both.

What you will find there

  • Answers to common patient and carer questions
  • Detailed articles on symptoms, treatments, tests, monitoring, and side effects
  • Practical explainers on issues such as damp, mould, air quality, medicines, and coping day to day
  • Recent updates and newly published articles in one place
  • Links into wider resources across our website

You do not need to read everything from start to finish. You can dip in when a particular question comes up, browse recent topics, or use the search function to look for something specific.

Built around real concerns

One of the strengths of this section is that it is grounded in real experience. The topics are not chosen at random. They reflect the concerns patients and carers bring to us repeatedly: the things people worry about, struggle to understand, or need explained more clearly.

That means the content is often practical, specific, and directly relevant to everyday life with aspergillosis.

Part of a wider knowledge base

If you want to browse recent questions and articles, this section is a very good place to start. If you are looking for more structured background information on aspergillosis, symptoms, tests, treatments, and monitoring, you can also move on from there to our wider Knowledge Hub.

Together, these resources are intended to make it easier for patients, families, and carers to find the information they need, when they need it.

Please use health information safely

As always, our website is here to support understanding, not replace medical advice from your own clinical team. We hope these articles help people feel better informed, better prepared, and better able to ask the right questions, but personal medical decisions should still be made with the professionals looking after your care.

Take a look

Explore the full section here:
Patient Questions & Latest Articles

If you think others may find it helpful, please feel free to share it.

by GAtherton

Why Join an Online Support Group if You Have Aspergillosis?

You are not alone with aspergillosis

Join a friendly online support meeting — no pressure, just listen if you prefer.

Many patients find that even attending once helps them feel more reassured, informed, and supported.


View meeting times and book your place

Why Join an Online Support Group if You Have Aspergillosis?

Living with aspergillosis can feel isolating. Many people go for years without meeting another person with the same condition. Family and friends may be supportive, but they may not fully understand what it is like to live with breathlessness, fatigue, treatment side effects, uncertainty, or repeated hospital visits.

That is one reason online support groups can be so valuable. They bring people together who understand, often immediately, many of the challenges that aspergillosis can bring.

Key points

  • Online support groups reduce isolation and help patients feel understood
  • They offer shared experience alongside emotional support
  • They improve confidence and understanding of the condition
  • They help patients feel better prepared for appointments
  • They are flexible — you can simply listen if you prefer

What changes when people join a support group?

Before joining

  • Feeling alone with the condition
  • Uncertainty about symptoms
  • Limited practical advice
  • Low confidence at appointments
  • Worry about the future

After joining

  • Connection with others who understand
  • Better understanding of the condition
  • Practical day-to-day coping ideas
  • More confidence asking questions
  • Feeling more supported and reassured

Why aspergillosis can feel so isolating

Aspergillosis is a relatively rare condition, and many patients never meet someone else with the same diagnosis. Online support groups help bridge that gap by creating a shared space for understanding and connection.

1. You realise you are not alone

Hearing others describe similar symptoms and challenges can be immediately reassuring and reduce feelings of isolation.

2. Shared experience can be deeply reassuring

Support groups provide practical, real-world insight into managing fatigue, pacing, work, and daily life.

3. You may understand your condition better

Listening to others and accessing shared resources helps build confidence and understanding.

4. It can help you feel more confident at appointments

Patients often feel better prepared and more able to ask the right questions.

5. Emotional support matters too

These groups provide encouragement, understanding, and a sense of belonging.

What happens in a typical online support session?

  • Friendly welcome — no pressure to speak
  • Open discussion — share or listen
  • Optional topics — such as fatigue or treatment experiences
  • Flexible participation — camera and microphone optional
  • Safe, moderated space

Many people attend their first session just to listen — and that is completely fine.

What patients often say

“I wish I had joined sooner. Just hearing others talk made a huge difference.”

“I didn’t speak in my first meeting, but it really helped just listening.”

“It helped me understand my condition and feel more confident.”

Thinking of joining?

You can attend once, listen, and decide if it feels helpful. There is no obligation to continue.

View meeting times and book here:

https://aspergillosis.org/support-meetings/

Meetings are held online using Microsoft Teams. You will receive a joining link after booking.

Bottom line

Online support groups offer connection, reassurance, and understanding. They cannot replace medical care, but they can make living with aspergillosis feel more manageable and less lonely.

Please note: These groups are for support and shared experience. They do not replace advice from your own doctor or specialist team.

by GAtherton